期刊
JOURNAL OF IMMUNOLOGY
卷 173, 期 9, 页码 5467-5475出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.173.9.5467
关键词
-
类别
资金
- NHLBI NIH HHS [K08 HL03979, R01 HL66279, T32 HL007974] Funding Source: Medline
- NIAMS NIH HHS [T32 AR07016-30] Funding Source: Medline
Chronic graft-vs-host disease (cGVHD) is an increasingly frequent complication of allogeneic stem cell transplantation. Phenotypically, cGVHD differs from patient to patient; in particular, a subset of patients develops extensive cutaneous fibrosis. Similarly, graft-vs-host disease (GVHD) is distinct in inbred murine donor:recipient pairings, indicating a genetic component to disease phenotype. The B10.D2 --> BALB/c (H-2(d)) strain pairing uniquely recapitulates key pathologic features of fibrotic human cutaneous cGVHD. To distinguish whether this genetic component is due to differences in genes that modulate immune responses or to the specific Ags targeted, we asked whether skin-dominant cGVHD also develops in the B10 --> BALB.B (H-2(b)) and B10.BR --> BALB.K (H-2(k)) MHC-congenic pairings. Because each MHC haplotype presents different peptides and selects different T cell repertoires, GVHD in each donor:recipient pair undoubtedly targets different Ags. We found that, in contrast to BALB/c recipients, BALB.B mice never manifested skin disease while BALB.K mice developed a modified form of skin disease. Instead, BALB.B and BALB.K recipients developed systemic GVHD which was absent in BALB/c mice. Moreover, in (B10 X B10.D2)F-1 --> (BALB.B X BALB/c)F-1 H-2(b/d) transplants, recipients developed both cutaneous and systemic disease. Thus, the selection of immunodominant Ags determines the target and character of GVHD, providing insight into the genetic basis for different forms of GVHD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据